BCG and Kawasaki disease in Mexico and Japan

References

• Yamada H, Ohta H, Hasegawa S, Azuma Y, Hasegawa M, Kadoya R, Ohbuchi N, Ohnishi Y, Okada S, Hoshide M, et al. Two infants with tuberculid associated with Kawasaki disease. Hum Vaccin Immunother 2016; 12:2772–2776
   Web of Science ®Google Scholar
• Uehara R, Igarashi H, Yashiro M, Nakamura Y, Yanagawa H. Kawasaki disease patients with redness or crust formation at the Bacille Calmette-Guérin inoculation site. Pediatr Infect Dis J 2010; 29:430-3; PMID:20032807; http://dx.doi.org/10.1097/INF.0b013e3181cacede
   PubMed Web of Science ®Google Scholar
• Sinha R, Balakumar T. BCG reactivation: a useful diagnostic tool even for incomplete Kawasaki disease. Arch Dis Child 2005; 90:891; PMID:16113127; http://dx.doi.org/10.1136/adc.2004.071332
   PubMed Web of Science ®Google Scholar
• Seo JH, Yu JJ, Ko HK, Choi HS, Kim YH, Ko JK. Diagnosis of incomplete kawasaki disease in infants based on an inflammation at the bacille calmette-guérin inoculation site. Korean Circ J 2012; 42:823-829; PMID:23323120; http://dx.doi.org/10.4070/kcj.2012.42.12.823
   PubMed Web of Science ®Google Scholar
• García Pavón S, Staines Boone T, Hernández Bautista V, Yamazaki Nakashimada MA. [Reactivation of the scar of BCG vaccination in Kawasaki's disease: clinical case and literature review]. [Article in Spanish] Rev Alerg Mex 2006; 53:76-8.
   PubMedGoogle Scholar
• Sireci G, Dieli F, Salerno A. T cells recognize an immunodominant epitope of heat shock protein 65 in Kawasaki disease. Mol Med 2000; 6:581-590; PMID:10997339
   PubMed Web of Science ®Google Scholar
• Nakamura T, Yamamura J, Sato H, Kakinuma H, Takahashi H. Vasculitis induced by immunization with Bacillus Calmette-Guérin followed by atypical mycobacterium antigen: a new mouse model for Kawasaki disease. FEMS Immunol Med Microbiol 2007; 49:391-7; PMID:17298582; http://dx.doi.org/10.1111/j.1574-695X.2007.00217.x
   PubMedGoogle Scholar
• Chun JK, Jeon BY, Kang DW, Kim DS. Bacille Calmette Guérin (BCG) can induce Kawasaki disease-like features in programmed death-1 (PD-1) gene knockout mice. Clin Exp Rheumatol 2011; 29:743-50; PMID:21906434
   PubMed Web of Science ®Google Scholar
• Karasawa R, Kurokawa MS, Yudoh K, Masuko K, Ozaki S, Kato T. Peroxiredoxin-2 is a novel autoantigen for anti-endothelial cell antibodies in systemic vasculitis. Clin Exp Immunol 2010; 161:459-70; PMID:20646000; http://dx.doi.org/10.1111/j.1365-2249.2010.04218.x
   PubMed Web of Science ®Google Scholar
• Fujieda M, Karasawa R, Takasugi H, Yamamoto M, Kataoka K, Yudoh K, Kato T, Ozaki S, Wakiguchi H. A novel anti-peroxiredoxin autoantibody in patients with Kawasaki disease. Microbiol Immunol 2012; 56:56-61; PMID:22003971; http://dx.doi.org/10.1111/j.1348-0421.2011.00393.x
   PubMed Web of Science ®Google Scholar
• Roth A, Gustafson P, Nhaga A, Djana Q, Poulsen A, Garly ML, Jensen H, Sodemann M, Rodriques A, Aaby P. BCG vaccination scar associated with better childhood survival in Guinea-Bissau. Inter J Epidemiol 2005; 34:540-7; PMID:15659474; http://dx.doi.org/10.1093/ije/dyh392
   PubMed Web of Science ®Google Scholar
• Garly ML, Martins CL, Balé C, Baldé MA, Hedegaard KL, Gustafson P, Lisse IM, Whittle HC, Aaby P. BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG? Vaccine 2003; 21:2782-90.
   PubMed Web of Science ®Google Scholar
• Freyne B, Marchant A, Curtis N. BCG-associated heterologous immunity, a historical perspective: intervention studies in animal models of infectious diseases. Trans R Soc Trop Med Hyg 2015; 109:287; PMID:25770252; http://dx.doi.org/10.1093/trstmh/trv021
   PubMed Web of Science ®Google Scholar
• Hsu YH, Wang YH, Hsu WY, Lee YP. Kawasaki disease characterized by erythema and induration at the Bacillus Calmette-Guérin and purified protein derivative inoculation sites. Pediatr Infect Dis J 1987; 6:576-8; PMID:3615073
   PubMed Web of Science ®Google Scholar
• Bertotto A, Spinozzi F, Vagliasindi C, Radicioni M, De Rosa O, Vaccaro R. Tuberculin skin test reactivity in Kawasaki disease. Pediatr Res 1997; 41:560–562; PMID:9098860; http://dx.doi.org/10.1203/00006450-199704000-00017
   Google Scholar
• Sato N, Sagawa K, Sasaguri Y, Inoue O, Kato H. Immunopathology and cytokine detection in the skin lesions of patients with Kawasaki disease. J Pediatr 1993; 122:198-203; PMID:8094096
   PubMed Web of Science ®Google Scholar
• Kuniyuki S, Asada M. An ulcerated lesion at the BCG vaccination site during the course of Kawasaki disease. J Am Acad Dermatol 1997; 37:303-4; PMID:9270532
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Yamamoto T. Historical review of BCG vaccine in Japan. Jpn J Infect Dis 2007; 60:331-6; PMID:18032829
   PubMed Web of Science ®Google Scholar
• Davids V, Hanekom WA, Mansoor N, Gamieldien H, Gelderbloem SJ, Hawkridge A, Hussey GD, Hughes EJ, Soler J, Murray RA, et al. The effect of bacille Calmette-Guérin vaccine strain and route of administration on induced immune responses in vaccinated infants. J Infect Dis 2006; 193:531-6; PMID:16425132; http://dx.doi.org/10.1086/499825
   PubMed Web of Science ®Google Scholar
• Jou R, Huang WL, Su WJ. Tokyo-172 BCG vaccination complications, Taiwan. Emerg Infect Dis 2009; 15:1525-6; PMID:19788832; http://dx.doi.org/10.3201/eid1509.081336
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang Z, Liu S, Sun J. Epidemiologic survey of Kawasaki disease in Jilin from 1999 through 2008. Pediatr Cardiol 2012; 33:272-9; PMID:21965088; http://dx.doi.org/10.1007/s00246-011-0121-7
   PubMed Web of Science ®Google Scholar
• Zhu H, Yu SF, Bai YX, Liang YY, Su XW, Pan JY. Kawasaki disease in children: epidemiology, clinical symptoms and diagnostics of 231 cases in 10 years. Exp Ther Med 2015; 10:357-61; PMID:26170962; http://dx.doi.org/10.3892/etm.2015.2487
   PubMed Web of Science ®Google Scholar
• Wang JF, Dai FY, Gong XL, Bao L. Commonly administered bacille Calmette-Guerin strains induce comparable immune resonse. Int J Clin Expe Med 2015; 9:15834-9.
   Google Scholar
• Ulloa-Gutierrez R, Salgado A, Dueñas L, Garrido-Garcia M, Estripeaut D, Faugier-Fuentes E, Camacho-Moreno G, Miño G, Saltigeral P, Gomez V, et al. BCG scar changes in Latin American infants and Children with Kawasaki disease: a prospective multinational multicenter study of the REKAMLATINA network. Abstract presented in IV Conference of Update in Pediatrics, Guadalajara Mexico, November 16-19 2015.
   Google Scholar
• Lin MT, Wang JK, Yeh JI, Sun LC, Chen PL, Wu JF, Chang CC, Lee WL, Shen CT, Wang NK, et al. Clinical implication of the C allele of the ITPKC gene SNP rs28493229 in Kawasaki disease: association with disease susceptibility and BCG scar reactivation. Pediatr Infect Dis J 2011; 30:148-52; PMID:20805785; http://dx.doi.org/10.1097/INF.0b013e3181f43a4e
   PubMed Web of Science ®Google Scholar
• Kawasaki T. Two cases with acute febrile mucocutaneous lymph node syndrome possibly induced by vaccinia or measles vaccination. Jpn J Pediatr 1970; 23:657-662. ( in Japanese)
   Google Scholar